Akia is one of several patients profiled in Novartis' digital campaign to raise awareness around the rare blood disorder ITP.
July 26, 2022 02:44 PM EDTUpdated July 29, 07:23 AM
Pharma
Marketing

Eye-catch­ing pho­tos spot­light pa­tients in No­var­tis’ ITP dig­i­tal and so­cial aware­ness cam­paign

Beth Snyder Bulik

Senior Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sum­mit says bis­pe­cif­ic miss­es over­all sur­vival in close­ly-watched lung can­cer study

Sum­mit’s dis­ap­point­ing sur­vival read­out rais­es stakes for full da­ta

An­oth­er Bris­tol My­ers ex­ec goes to Aca­dia; David South­well takes CEO job at ARCH-backed can­cer biotech

As a chal­leng­ing first half nears a close, bio­phar­ma un­cer­tain­ty per­sists

Sanofi, Re­gen­eron re­port un­der­whelm­ing COPD da­ta for IL-33 an­ti­body, shares drop

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times